Member Info for NFTs

Https://patentscope.wipo.int/search/docs2/wipocase/JP344317072/pdf/u9lMVt29FvRZt3uIKtQmbZDAY5suYYNaPPQkyHsL0N1lk4he5h2fwqis3l3vZu708MtGQb0850-65RPyPGN-l7vx6Of1a0mlIdvYUK1eHyihGP7ZfdxnIht4yDALZuu_cLifZeFWdi91vNScTXTtHc4nQ6AG008mqx1wkTMEeyMc3pL-zYzP6L_9sssxFSjbjqPzdr1fbAsNGprtDg_zjd6JRfE-S9BXLPkwAAwmSTJkaRDNBTXt3Hw9joE3-c3RF3KaupEi-qb0kE6P1UJD2K8n9TrY2Lp5z4hE91-qceg?filename=Claims_(TRANSLATED).pdf

I have the document here in front of me. So yes I know exactly what it stated.

Removing of that solution degrades the patent. It was there for a reason!

I know exactly what they have put and I also no exactly that they don’t know if that will get passed.

I also know exactly what I stated and the facts you stated below which as I said misconstrued what I said and you now try cover it up.

They don’t have the patent

They cannot negotiate without that confirmation

They didn’t inform anyone that this was going on during investors meets.

There is no guarantee

They have no money

They have passed on NXP001 because they cannot even afford to maintain its patent portfolio

Oxcillio acquired I believe for 500,000 shares a certain someone’s consultant firm that had intellectual knowledge on Nuformix!!

So to broaden the horizon on that. Who profited out of NXP001

To say royalties and milestones of any sort will benefit a shareholder here is laughable. NFX won’t be in existence.

You continually stated that they were getting product NXP001 pushed along by OX and money would be coming lol

Yep you got couple k and now gone lol

Arrogance never pays.

“Moreover, a concrete ground for supporting the applicant's allegation (experimental results, etc.) is not presented. Therefore, the aforementioned allegation of the applicant is unacceptable. ”

11 and 12 strongly refused.

Will that do primary school teacher!

Play the ball not the player for one.

Secondly you are ignoring the fact that I stated they don’t have the patent.

You ignore the fact I stated they didn’t inform investors and again play games with they holders by not informing them of very significant issues.

You also ignore the fact you certainly cannot entertain any negotiations if you haven’t got the patent sorted!

You have no patent and it’s only just had amendment sent to try sort out the refusal on two counts.

So

To repeat, They don’t have the patent you are currently in a position where it has been strongly refused on two counts and are unable to know if they could turn this around.

You are not able to say to clients you have rights to protection therefore they won’t even entertain you.

The company never informed anybody on this matter. Please show me the RNS from March showing patent refusal to inform its investors!

Please show me in the meetings done since by the company where they informed the investors?

No.

They have submitted a request.

It’s not been processed and awaits review.

Therefore you don’t have the patent and the product is at high risk. Therefore not possible to say to interested parties that you actually have protection of it.

Bit like dragon’s den. You know when they ask the candidates if they have secured the patent etc and then they give excuses and that’s it. Bye bye!!!

It’s seriously embarrassing and naughty to have hidden this from March to only the other month.

I can see this getting delisted soon. Kind of runs with the family of those stocks that directors of Leveret holdings CTAG Berm Ebers Seem to have form.

They promise loads of huge things with massive numbers created out of fluff and raise capital at pennies but list many multiples of that and get the private investors in at high levels. Then place multiple times trapping investors in at sky high numbers causing them to average down again and again till they can take no more and lights go out.

I see that now rolling in rapidly here. Family silver has started to be flogged off at peanuts to try keep it operational in hope good fortune arrives. You never know. Problem is these outfits normally fail now! Someone will get the product but not investors!

When it comes to trust! Funny how the board of directors in their pumping meetings and telegram chats don’t mention issues with the one thing that matters and that’s the patent for NXP002! You better hope they can sort this and again as mentioned! How could you even negotiate with partners when you don’t even have the basics covered on your product you want to flog them!

Looks very embarrassing imo

S 25 °C or 37 °C and the cited document 1 is 5 °C). Since these results cannot be said to be clearly different from each other, the allegation that the two are different from each other is groundless. Moreover, a concrete ground for supporting the applicant's allegation (experimental results, etc.) is not presented. Therefore, the aforementioned allegation of the applicant is unacceptable.

At present, no reasons for refusal are found with respect to the inventions according

to Claims ( 1-10,13-21 ) at present at this point.

1.JP 2006-306765A

------------------------------------------------------------------------

The applicant who is dissatisfied with the examiner's decision, may file a request

for a trial against examiner's decision of refusal to the Commissioner of the Japan

Patent Office within three months (where overseas resident, within four months) from

the date when the copy of the examiner's decision has been served (refer

As I mentioned this has no value if this gets refused again! A lot hangs on them getting this. Looks like bad blood in Japan from Kissie pulling them up to protect their drug.

“Notice of Transfer of a Case for Reconsideration by Examiners before Appeal

Proceedings

Reiwa 5(2023) September 14

Commissioner of the Patent Office

Number of the request/demand for appeal/trial: Appeal 2023 - 12306

(Application number) : (Japanese Patent Application No. 2020-555115)

Demandant: **** mix Technologies Limited

Representative patent attorney: ASAMURA PATENT OFFICE

Since there was correction about a Description, a scope of the claim, or Drawings

simultaneously with the request/demand for appeal/trial, and an examiner is made to

examine in accordance with the provisions of Article 162 of the Patent Act

(reconsideration by examiners before appeal proceedings), we announce you this the

case of appeal against the examiner's decision of refusal.

Specialist for Formality Examination ODA, Naomi T664”

“Decision of Refusal

Application number: Japanese Patent Application No. 2020-555115

Date of Drafting: Reiwa 5(2023) March 9

Patent examiner: TSUCHIHASHI, Keisuke 3839 4H00

Title of the invention:Tranilast salts and pharmaceutical use thereof

Applicant: **** mix Technologies Limited

Representative: ASAMURA PATENT OFFICE

This application should be refused for the reason 1,2 mentioned in the Notice of

Reasons for Refusal dated 10/28/Reiwa 4. Although the written opinion and the written

amendment have been examined, no basis sufficient to overthrow the previously given

reason(s) for refusal has been found.

Remarks

Regarding Reasons 1 and 2 (Article 29 (1) (I) and Article 36 (2) (I) of the Patent

Act) 3

- Claim 11,12

- Cited Document, etc. 1

- Remarks

Reasons 1 and 2 on the basis of the cited document 1 are as pointed out in the

previous notification of reasons for refusal. In the written opinion, "A 1:1

Tranilast potassium hydrate salt of the inventions according to Claims 11 and 12 of

the present application" While high water solubility and high solubility stability

are exhibited (Examples 13 and 14), the crystals of Comparative Example 1 described

in Table 7 of Cited Document 5 and the crystals of Comparative Examples 14 and 15

described in Table 9 are precipitated as sparingly soluble salts (crystals) in an

aqueous solution. Therefore, the characteristics of the two are different from each

other, and it is reasonable to understand that the salt described as a comparative

example in Cited Document 1 is characterized by the specific powder X-ray diffraction

pattern, and that it is not a 1:1 Tranilast potassium monohydrate salt. ". However,

working Examples 13 and 14 in the description of the present application and Tables 7

and 9 in Cited Document 1 differ in terms of the dissolving conditions, and in particular, in the case of Cited document 1, the temperature of the aqueous solution is considerably lower (the present

AstraZeneca have been in the background for well over a year. They need this. The problem is as one goes forward they need to deliver a bid that actually values the asset correctly immaterial to what silly MCAP we currently are.

What they need though is to prove to their shareholders why they have to stump up 20 billion etc. This is the crux they face. We know the platform is going to continue to move down the line and grow. AS and his team want to do that but the Majors will have their own IP and returns to protect along with the never ending requirement to feed their continued growth and dividends to investors, so they seek out the next future drugs.

AVACTA threatens many Majors assets and the preCison platform is overwhelmingly showing the world its abilities to enhance proven valuable drugs. Taking them from those companies.

With things now speeding up significantly with basically Phase 2 now in progress to start next year we are in the firing line for aggressive approaches.

The main point though is they need to gauge their bid right!! As others will come in also causing a bidding war. It’s almost like the Majors want to keep their heads stuck in the sand because they cannot face messing up the approach to a business that if not squired could wipe out many billions of their current assets and revenues.

Game on

This was one of the desperate last chances they had. Pennies is what they got!

Cannot even afford pennies to maintain the patent. As mentioned not even close to any deal. NXP004 not worth the paper it’s written on and cannot even flog the patent.

NXP002 requires more tests and they haven’t any money.

One more placing and then it’s lights out. Desperately trying to claw something back. Remember Dans consulting firm he sold!! Hence NXP001 money got sold away without the company getting the money in underhanded way imo.

The smoke and mirrors continues that they cannot even call this payment significant and the last NXP001 payment which was significant of 50k lol. When they have no money even 5k would be significant here now lol lol lol lol lol. S H * T sandwich classic DG style.

Plenty here trapped licking wounds desperate to try claw a little loss back.

You always avoid stating that the Human lung tissue tests were after results those cost £300,000 plus hence the raise for 70k

It’s there in black and white!

“ The time it takes for a revised patent to be processed can vary depending on several factors, such as the complexity of the revisions and the workload of the patent office handling the application. On average, it can take anywhere from several months to a few years for a revised patent to be processed. It is best to consult with a patent attorney or the patent office itself for more accurate information regarding your specific situation.”

It’s going to be sometime still waiting here. Money is only going out and there is only one way to secure the future for another year!!!

Bills salaries and accountancy broker meetings travel costs.

Ready for insertion as explained

Get ready for the insertion lol

How many times have we heard this about how CLN’s initially sound like a great possibility but the truth is it was the only option of debt raising it will end in the usual mess.

I’ll tell you why. They are three years away minimum to getting into possible break even here.

What will happen is initial LTH will try buy in to reduce their average. Once that happens and new investors see the CLN’s there and the fact the accounts show terrible profit to loss margins and the fact it’s just going slower than predicted to gain a sustainable business. They realise in 1 year another raise is required as the loan notes get to point of conversion the SP will collapse. This cloud will hang over causing issues. Watch and see.

Definitely poor. No other option 45% dilution and it will only keep the lights on for 12 months. If not sold it will collapse. Just delayed the inevitable

Looks like Lanstead are really struggling to off load them and I really do wander if it was a nominee account for Lanstead that took this last placing shares.

One thing with this company is that they have always hidden the truth and try to hide things.

No hiding that a big placing is coming at the AGM. They need to vote to get any cash here as the MCAP is so pitiful and it’s going to get a lot worse.

Won’t be long until they are switched off from Lanstead unless Lanstead used a different nominee to hide the other 35 million shares?

But once they go that selling just under the buy price will aid a drop below 0.2p